GENITAL PROLAPSE

This adverse event was reported 56 times

GENITAL PROLAPSE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FOSAMPRENAVIR CALCIUM 1 0.0076
1 LAMIVUDINE AND ZIDOVUDINE 7 0.0009
2 EFAVIRENZ 7 0.0006
3 ABACAVIR SULFATE 4 0.0004
4 RALTEGRAVIR 2 0.0004
5 ALENDRONATE SODIUM AND CHOLECALCIFEROL 1 0.0004
6 ZIDOVUDINE 3 0.0003
7 LAMIVUDINE 7 0.0003
8 SELENIUM 1 0.0002
9 TAMOXIFEN CITRATE 1 0.0002
See all drugs enriched for association with GENITAL PROLAPSE